<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>UNLABELLED: This study aimed to assess whether (18)F-FDG PET could serially monitor the beneficial effects of bone marrow stromal cells (BMSC) on cerebral <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism when transplanted into the <z:mpath ids='MPATH_124'>infarct</z:mpath> brain of rats </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: The BMSC from green fluorescent protein transgenic rats or vehicle was stereotactically transplanted into the ipsilateral striatum at 7 d after permanent middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> of rats </plain></SENT>
<SENT sid="2" pm="."><plain>Local <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism was semiquantitatively measured at 6 and 35 d after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> using (18)F-FDG PET </plain></SENT>
<SENT sid="3" pm="."><plain>Motor function was serially evaluated throughout the experiments </plain></SENT>
<SENT sid="4" pm="."><plain>At 35 d after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, immunohistochemistry was performed to evaluate the phenotype of BMSC and their effects on the expression of brain-type <z:chebi fb="105" ids="17234">glucose</z:chebi> transporters </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: BMSC transplantation not only enhanced functional recovery but also promoted the recovery of <z:chebi fb="105" ids="17234">glucose</z:chebi> utilization in the periinfarct area when stereotactically transplanted at 1 wk after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>The engrafted cells were widely distributed, and most expressed a neuron-specific protein, NeuN </plain></SENT>
<SENT sid="7" pm="."><plain>BMSC transplantation also prevented the pathologic upregulation of <z:chebi fb="105" ids="17234">glucose</z:chebi> transporters in the periinfarct neocortex </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: The present findings strongly suggest that the BMSC may enhance functional recovery by promoting the recovery of local <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism in the periinfarct area when directly transplanted into the <z:mpath ids='MPATH_124'>infarct</z:mpath> brain at clinically relevant timing </plain></SENT>
<SENT sid="9" pm="."><plain>The BMSC also inhibit the pathologic upregulation of brain-isoform <z:chebi fb="105" ids="17234">glucose</z:chebi> transporters type 1 and 3 </plain></SENT>
<SENT sid="10" pm="."><plain>(18)F-FDG PET may be a valuable modality to scientifically prove the beneficial effects of BMSC transplantation on the host brain in clinical situations </plain></SENT>
</text></document>